Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

The surgical management of sarcomas of the chest wall: A 13-year single institution experience

Lookup NU author(s): Richard Milner

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© 2020 Elsevier Ltd. Introduction: Chest wall sarcomas are rare. Resection and reconstruction pose significant anatomical and functional challenges. We present our experience of managing these tumours as plastic surgeons working within a specialist sarcoma MDT. Methods: All cases of chest wall sarcoma in which a plastic surgeon took part were analysed (2003–2016). Tumours of the breast, abdomen and groin were excluded. Demographics, surgical details and outcomes were analysed. Results: Forty-seven patients were identified. Median age at presentation was 61 years (range 7–91). Thirty-three were male and 14 were female. Chondrosarcoma (n = 16) was the most frequently occurring tumour, followed by myxofibrosarcoma (n = 6), leiomyosarcoma (n = 5) and unclassified sarcomas (n = 5). The majority of tumours were of high (n = 16) or intermediate grade (n = 17) histologically. Wide local excision was carried out in all cases. Twenty-two cases required a mesh and cement reconstruction of the chest wall. Soft tissue reconstruction involved pedicled LD flap +-skin graft (n = 17), direct closure (n = 13), pedicled VRAM (n = 7), free ALT flap (n = 6), and others (n = 4). Clear resection margins were achieved in 32 patients (68%). Fourteen patients underwent adjuvant radiotherapy and four adjuvant chemotherapy. Nine patients (19%) developed a local recurrence, and the median duration from resection to recurrence was 17 months (range 3–72). Nine patients (19%) developed metastasis. Eleven patients died (23.4%), and the median duration of survival 30 months (range 3–92). Thirty-six patients remain well, with a median duration of follow up 57.5 months (range 6–141). Estimated 5 year disease specific survival is 74.2%. Conclusion: Plastic surgeons have a vital role in the management of chest wall sarcomas. We present a reconstructive algorithm, which has enabled us to achieve good oncological and functional outcomes and a low complication profile.


Publication metadata

Author(s): Crowley TP, Atkinson K, Bayliss CD, Barnard S, Milner RH, Ragbir M

Publication type: Article

Publication status: Published

Journal: Journal of Plastic, Reconstructive and Aesthetic Surgery

Year: 2020

Volume: 73

Issue: 8

Pages: 1448-1455

Print publication date: 01/08/2020

Online publication date: 04/03/2020

Acceptance date: 16/02/2020

ISSN (print): 1748-6815

ISSN (electronic): 1878-0539

Publisher: Churchill Livingstone

URL: https://doi.org/10.1016/j.bjps.2020.02.036

DOI: 10.1016/j.bjps.2020.02.036


Altmetrics

Altmetrics provided by Altmetric


Share